Protection against Experimental Cryptococcosis following Vaccination with Glucan Particles Containing Cryptococcus Alkaline Extracts

A vaccine capable of protecting at-risk persons against infections due to Cryptococcus neoformans and Cryptococcus gattii could reduce the substantial global burden of human cryptococcosis. Vaccine development has been hampered though, by lack of knowledge as to which antigens are immunoprotective a...

Descripción completa

Detalles Bibliográficos
Autores principales: Specht, Charles A., Lee, Chrono K., Huang, Haibin, Tipper, Donald J., Shen, Zu T., Lodge, Jennifer K., Leszyk, John, Ostroff, Gary R., Levitz, Stuart M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Microbiology 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4701832/
https://www.ncbi.nlm.nih.gov/pubmed/26695631
http://dx.doi.org/10.1128/mBio.01905-15

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4701832/
https://www.ncbi.nlm.nih.gov/pubmed/26695631
http://dx.doi.org/10.1128/mBio.01905-15

Ejemplares similares